TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
B/P-Pharma AB
Closing information (x1000 SEK)
Closing information | 2023/04 | 2022/04 | 2021/04 |
Turnover |
12,678
|
11,834
|
11,731 |
Financial expenses |
0
![]() |
0
|
1 |
Earnings before taxes |
333
|
317
|
161 |
EBITDA |
538
|
325
|
178 |
Total assets |
5,129
|
4,695
|
4,762 |
Current assets |
4,315
|
4,667
|
4,727 |
Current liabilities |
1,466
|
1,310
|
1,634 |
Equity capital |
3,412
|
3,154
|
2,906 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
3
![]() |
3
![]() |
3 |
Financial ratios
Fiscal year | 2023/04 | 2022/04 | 2021/04 |
Solvency |
66.5%
|
67.2%
|
61.0% |
Turnover per employee |
4,226
|
3,945
|
3,910 |
Profit as a percentage of turnover |
2.6%
|
2.7%
|
1.4% |
Return on assets (ROA) |
6.5%
|
6.8%
|
3.4% |
Current ratio |
294.3%
|
356.3%
|
289.3% |
Return on equity (ROE) |
9.8%
|
10.1%
|
5.5% |
Change turnover |
844
|
103
|
163 |
Change turnover % |
7%
|
1%
![]() |
1% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/04 | 2022/04 | 2021/04 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.